Data from NPC and CEVR reveal utilization management is common even when clinical guidelines do not support its use. WASHINGTON, DC, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- New research by ...

House GOP clears measure to claw back billions from foreign assistance and public media programs The Senate will take up this initial effort to codify some Department of Government Efficiency cuts ...

MRO Corp. (MRO), the leading clinical data exchange company in healthcare, announced today the acquisition of Q-Centrix Corp. (Q-Centrix), a leading enterprise clinical data management platform ...

By transforming clinical data from raw records into enriched, curated data assets, MRO and Q-Centrix create scalable value that supports more precise decision-making and broader clinical applications.

President Donald Trump said Tuesday that he plans to phase out the Federal Emergency Management Agency after this year’s hurricane season, offering the clearest timeline yet for his ...

Katter's Australian Party is proposing new legislation that would allow crocodile culls and safari style hunting trips in Queensland. That bill is currently before a parliamentary inquiry.

The city is hosting a review of its five-year update to its marsh management plan Tuesday night. Experts studied the land and changes they recorded before making their recommendations. Click here to ...

The White House is approving disaster relief funds without notifying FEMA, leading to delays and confusion ...

OPM ‘merit’ hiring plan includes bipartisan reforms, politicized new test The federal government’s HR agency on Thursday instructed agencies to cease collecting data on the demographic ...

Less than two weeks until the official start of the Atlantic hurricane season, Federal Emergency Management Agency acting Administrator David Richardson has rescinded the agency's strategic plan ...

Mismatch repair–deficient (dMMR) tumors are highly sensitive to immune checkpoint blockade, and in the context of metastatic disease, a substantial clinical benefit has been seen with this ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.